ESMO Clinical Practice Guidelines News
Keep up to date with news about ESMO guidelines, including the latest CPG publications, updated recommendations, algorithms, pocket guidelines and MCBS grading.
New Consensus Guidelines
19 June 2018: Online publication of the ESMO Consensus Guidelines for the Management of Patients with Malignant Lymphoma - Management of ‘ultra-high-risk’ Patients
New Clinical Practice Guidelines
6 June 2018: ESMO Clinical Practice Guidelines: Primary cutaneous lymphomas
New Clinical Practice Guidelines
28 May 2018: ESMO-EURACAN Clinical Practice Guidelines: Gastrointestinal Stromal Tumours
New Clinical Practice Guidelines
28 May 2018: ESMO-EURACAN Clinical Practice Guidelines: Soft Tissue and Visceral Sarcomas
New Clinical Practice Guidelines
23 May 2018: ESMO Clinical Practice Guidelines: Hodgkin Lymphoma
New Clinical Practice Guidelines
25 April 2018: ESMO Clinical Practice Guidelines: Non-epithelial ovarian cancer
New Clinical Practice Guidelines Slide Set
ESMO Clinical Practice Guidelines: Early and locally advanced non-small-cell lung cancer (NSCLC)
New Clinical Practice Guidelines
20 February 2018: ESMO Clinical Practice Guidelines: Management of anaemia and iron deficiency in patients with cancer
New Thyroid Cancer Treatment Recommendation
19 February 2018: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendation for Thyroid Cancer
Pan-Asian Adapted ESMO Consensus Guidelines
Pan-Asian Adapted ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer
New Treatment Algorithms
9 November 2017: New eUpdate featuring Diagnostic and Treatment Algorithms for Advanced Breast Cancer
New 2017 Pocket Guidelines
4 October 2017:The 2017 pocket guidelines are available now on the ESMO Cancer Guidelines mobile app!
New Treatment Recommendations
28 September 2017: New eUpdate featuring Treatment Recommendation for Prostate Cancer
New 2017 Clinical Practice Guidelines
13 July 2017: Three new titles:
EANO and ESMO Guidelines on Leptomeningeal Metastasis from Solid Tumours,
Management of Infusion Reactions to Systemic Anticancer Therapy and
Management of Toxicities from Immunotherapy.
Six updated guidelines:
Early and Locally Advanced NSCLC,
Rectal Cancer,
Chronic Myeloid Leukaemia,
Multiple Myeloma,
Newly Diagnosed and Relapsed Mantle Cell Lymphoma and
Cervical Cancer
New Treatment Recommendations
29 June 2017: New eUpdate featuring Updated Treatment Recommendations and Tables for Testicular Seminoma and Non-Seminoma
New Treatment Algorithms
28 June 2017: New eUpdate featuring Updated Treatment Algorithms for Metastatic Non-small-cell Lung Cancer
Treatment Recommendations and Revised ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading
28 June 2017: New eUpdate featuring Treatment Recommendations and Revised ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading for Metastatic Non-small-cell Lung Cancer
New Chronic Lymphocytic Leukaemia Treatment Recommendations
27 June 2017: New eUpdate featuring Updated Treatment Recommendations and Algorithms for Chronic Lymphocytic Leukaemia
New Pancreatic Cancer Treatment Recommendation
20 June 2017: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendation for Pancreatic Cancer
New Endometrial Cancer Algorithms
8 June 2017: New eUpdate featuring Diagnostic Work-up, Staging and Treatment Algorithms for Endometrial Cancer
Updated Soft Tissue Sarcoma Treatment Recommendations
5 May 2017: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading for Soft Tissue Sarcoma
Updated Clinical Practice Guidelines
27 April 2017: ESMO Clinical Practice Guidelines:Multiple Myeloma
Updated Advanced Breast Cancer Treatment Recommendations
25 April 2017: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading for Advanced Breast Cancer
New Renal Cell Carcinoma Treatment Recommendations
10 April 2017: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendations for Renal Cell Carcinoma
Video: Integrating ESMO-MCBS scores into the ESMO Clinical Practice Guidelines
10 April 2017: Elisabeth de Vries and George Pentheroudakis explain how newly registered drugs are graded according to the ESMO-MCBS, and how scores are integrated into the ESMO Clinical Practice Guidelines
New Consensus Guidelines
5 December 2016: Online publication of the 3rd ESO–ESMO International Consensus Guidelines on Advanced Breast Cancer (ABC 3)
New 2016 Pocket Guidelines
4 November 2016: The 2016 pocket guidelines are available now on the Cancer Guides mobile app!
Download the app for the latest guidelines on Leukaemia & Myeloma, Upper and Lower Gastrointestinal Cancers, Lung & Chest Tumours, Lymphomas, Urogenital Cancer, Gynaecological Malignancies and Supportive Care.
New Consensus Guidelines
4 October 2016: Online publication of the ESMO Consensus Guidelines for the Management of Patients with Malignant Lymphoma - Prognostic Factors Suitable for Clinical Use
New 2016 Clinical Practice Guidelines
23 September 2016: In addition to three new titles:
Acute lymphoblastic leukaemia in adult patients,
Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma,
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes we have also updated the following eight guidelines:
Metastatic non-small-cell lung cancer,
Biliary cancer,
Gastric cancer,
Oesophageal cancer,
Renal cell carcinoma,
Newly diagnosed and relapsed follicular lymphoma,
Management of febrile neutropaenia,
MASCC and ESMO Consensus Guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting.
New Prostate Cancer Diagnostic Work-up, Staging and Treatment Algorithms
22 September 2016: New eUpdate featuring New Diagnostic Work-up, Staging and Treatment Algorithms Recommendations for Prostate Cancer
New Ovarian Cancer Personalised Medicine Treatment Recommendations
21 September 2016: New eUpdate featuring Updated Treatment Recommendations for Ovarian Cancer
New Metastatic Colorectal Cancer Treatment Recommendations
20 September 2016: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendations for Metastatic Colorectal Cancer
New Neuroendocrine Tumours Treatment Recommendations
20 September 2016: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendations for Neuroendocrine Tumours
New Cutaneous Melanoma Treatment Recommendations
19 September 2016: New eUpdate featuring ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendations for Cutaneous Melanoma
New Cutaneous Melanoma Algorithms
19 September 2016: New Algorithms for Diagnostic Work-up, Staging and Treatment of Cutaneous Melanoma
New Consensus Guidelines
5 July 2016: Online publication of the ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer
New Clinical Practice Guidelines
4 July 2016: ESMO Clinical Practice Guidelines: Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
New Clinical Practice Guidelines
7 April 2016: New ESMO Clinical Practice Guidelines: Acute Lymphoblastic Leukaemia
Guidelines Methodology Published
23 March 2016: ESMO guidelines methodology published online - full SOPs for development of Clinical Practice Guidelines and Consensus Conferences